2021, Número 2
<< Anterior Siguiente >>
Cir Card Mex 2021; 6 (2)
Palliative Surgical Procedures vs Duct or Right Ventricular Outflow Stent in neonates with ductus dependent pulmonary blood flow
Rendón-Elías FG, Castro-Medina M, de la Cerda-Belmont GA, Anaya-Medina G, Hernández-Sánchez M, Gómez-Danés LH
Idioma: Ingles.
Referencias bibliográficas: 124
Paginas: 40-53
Archivo PDF: 327.60 Kb.
RESUMEN
Una medida del progreso en la medicina es la introducción
de opciones de tratamiento nuevas y superiores, que naturalmente
reemplazan las formas de terapia más antiguas. A
veces, las opciones de tratamiento recién introducidas compiten,
en lugar de reemplazar, tratamientos más antiguos y
establecidos. Esto es especialmente cierto cuando diferentes
formas de terapia para la misma enfermedad tienen su origen
en diferentes disciplinas. En consonancia con las tendencias
recientes en el tratamiento de las cardiopatías congénitas,
han sido introducidos procedimientos basados en
técnicas percutáneos para el tratamiento de las cardiopatías
congénitas cianóticas con flujo sanguíneo pulmonar dependiente
del conducto en recién nacidos. En este artículo describimos
los procedimientos paliativos endovasculares quirúrgicos
y percutáneos que se pueden realizar en neonatos
que tienen contraindicaciones para realizar una reparación
completa de sus malformaciones cardíacas congénitas cianóticas,
incluyendo sus ventajas, complicaciones, resultados y
desenlaces.
REFERENCIAS (EN ESTE ARTÍCULO)
Yuan SM, Jing H. Palliative procedures for congenital heart defects. Arch CardiovascDis 2009;102:549-57. doi: 10.1016/j.acvd.2009.04.011.
Blalock A, Taussig HB. Landmark article May 19, 1945: The surgical treatmentof malformations of the heart in which there is pulmonary stenosis or pulmonaryatresia. By Alfred Blalock and Helen B. Taussig. JAMA 1984;251:2123-38. doi:10.1001/jama.251.16.2123.
Potts WJ, Smith S, Gibson S. Anastomosis of the aorta to a pulmonary artery;certain types in congenital heart disease. J Am Med Assoc. 1946;132:627-31. doi:10.1001/jama.1946.02870460017005.
Waterston DJ. Treatment of Fallot’s tetralogy in children under 1 year of age.Rozhl Chir 1962; 41:181-3.
Cooley DA, Hallman GL. Intrapericardial aortic-right pulmonary arterial anastomosis.Surg Gynecol Obstet 1966;122:1084-6.
Gazzaniga AB, Elliott MP, Sperling DR, et al. Microporous expanded polytetrafluoroethylenearterial prosthesis for construction of aortopulmonary shunts:experimental and clinical results. Ann Thorac Surg 1976;21:322-7. doi: 10.1016/s0003-4975(10)64320-2.
McKenzie ED, Khan MS, Samayoa AX, et al. The Blalock-Taussig shunt revisited:a contemporary experience. J Am Coll Surg. 2013;216:699-704; discussion704-6. doi: 10.1016/j.jamcollsurg.2012.12.027.
Mavroudis C, Backer CL. Palliative operations. In: Mavroudis C, Backer CL(eds). Pediatric Cardiac Surgery. 4th ed. Philadelphia: Mosby, 2013, 160–70.ISBN: 978-1-405-19652-9.
Geiss D, Williams WG, Lindsay WK, Rowe RD. Upper extremity gangrene: acomplication of subclavian artery division. Ann Thorac Surg 1980;30:487-9. doi:
10.1016/s0003-4975(10)61302-1.10. de Leval MR, McKay R, Jones M, Stark J, Macartney FJ. Modified Blalock-Taussigshunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts. J Thorac Cardiovasc Surg 1981;81:112–9. doi:10.1016/S0022-5223(19)37668-8.
Williams JA, Bansal AK, Kim BJ, et al. Two thousand Blalock-Taussig shunts: asix-decade experience. Ann Thorac Surg 2007;84:2070-5; discussion 2070-5. doi:10.1016/j.athoracsur.2007.06.067.
Eghtesady P, Ghanamah SM. Fallot: Palliation with BT Shunt. In: Lacour-GayetF, Bove EL, Hraska V, Morell VO, Spray TL (ed). Surgery of ConotruncalAnomalies. Switzerland Springer, 2016; 189-20. ISBN: 978-3-319-23057-3. doi:10.1007/978-3-319-23057-3.
Odim J, Portzky M, Zurakowski D, et al. Sternotomy approach for the modifiedBlalock-Taussig shunt. Circulation 1995;92: II256–61.
Shauq A, Agarwal V, Karunaratne A, et al. Surgical approaches to the Blalockshunt: does the approach matter? Heart Lung Circ 2010; 19:460–4.
Talwar S, Kumar MV, Muthukkumaran S, Airan B. Is sternotomy superior to thoracotomyfor modified Blalock-Taussig shunt? Interact Cardiovasc Thorac Surg.2014;18:371-5. doi:10.1093/icvts/ivt513.
Dirks V, Prêtre R, Knirsch W, etal. Modified Blalock Taussig shunt: a not-sosimplepalliative procedure. Eur J Cardiothorac Surg 2013;44:1096-102. doi:10.1093/ejcts/ezt172.
Gedicke M, Morgan G, Parry A, Martin R, Tulloh R. Risk factors for acute shuntblockage in children after modified Blalock-Taussig shunt operations. Heart Vessels2010; 25:405–9. doi: 10.1007/s00380-009-1219-1.
Petrucci O, O'Brien SM, Jacobs ML, Jacobs JP, Manning PB, Eghtesady P. Riskfactors for mortality and morbidity after the neonatal Blalock-Taussig shunt procedure.Ann Thorac Surg 2011;92:642-51; discussion 651-2. doi: 10.1016/j.athoracsur.2011.02.030.
McKenzie ED, Khan MS, Samayoa AX, et al. The Blalock-Taussig shunt revisited:a contemporary experience. J Am Coll Surg. 2013;216:699-704; discussion 704-6.doi: 10.1016/j.jamcollsurg.2012.12.027.
Bove T, Vandekerckhove K, Panzer J, De Groote K, De Wolf D, FrançoisK. Disease-specific outcome analysis of palliation with the modifiedBlalock-Taussig shunt. World J Pediatr Congenit Heart Surg 2015;6:67–74. doi:10.1177/2150135114558690.
Lamberti JJ, Carlisle J, Waldman JD, et al. Systemic-pulmonary shunts in infantsand children. Early and late results. J Thorac Cardiovasc Surg 1984;88:76–81.
Gold JP, Violaris K, Engle MA, Klein AA, Ehlers KH, Lang SJ, Levin AR, MoranF, O'Loughlin JE, Snyder MS, et al. A five-year clinical experience with 112Blalock-Taussig shunts. J Card Surg. 1993;8:9-17. doi: 10.1111/j.1540-8191.1993.tb00571.x.
Gladman G, McCrindle BW, Williams WG, Freedom RM, Benson LN. The modifiedBlalock-Taussig shunt: clinical impact and morbidity in Fallot's tetralogy inthe current era. J Thorac Cardiovasc Surg 1997;114:25-30. doi: 10.1016/S0022-5223(97)70113-2.
Alkhulaifi AM, Lacour-Gayet F, Serraf A, Belli E, Planché C. Systemic pulmonaryshunts in neonates: early clinical outcome and choice of surgical approach. AnnThorac Surg 2000;69:1499-504. doi: 10.1016/s0003-4975(00)01078-x.
Williams JA, Bansal AK, Kim BJ, et al. Two thousand Blalock-Taussig shunts: asix-decade experience. Ann Thorac Surg 2007;84:2070-5; discussion 2070-5. doi:10.1016/j.athoracsur.2007.06.067.
Vitanova K, Leopold C, von Ohain JP, Wolf C, Beran E, Lange R, Cleuziou J. Reasonsfor Failure of Systemic-to-Pulmonary Artery Shunts in Neonates. Thorac CardiovascSurg 2019;67:2-7. doi: 10.1055/s-0037-1621706.
Vitanova K, Leopold C, Pabst von Ohain J, Wolf C, Beran E, Lange R, Cleuziou J.Risk Factors for Failure of Systemic-to-Pulmonary Artery Shunts in BiventricularCirculation. Pediatr Cardiol 2018;39:1323-9. doi: 10.1007/s00246-018-1898-4.
Tsai KT, Chang CH, Lin PJ, et al. Modified Blalock-Taussing shunt: statistical analysisof potential factor influencing shunt outcome. J Cardiovasc Surg 1996; 37.149-52.
Tamisier D, Vouhé PR, Vernant F, Lecá F, Massot C, Neveux JY. ModifiedBlalock-Taussig shunts: results in infants less than 3 months of age. Ann ThoracSurg. 1990;49:797-801. doi: 10.1016/0003-4975(90)90026-3.
Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediatorin atherothrombosis? Hypertension 2004;44:6-11. doi: 10.1161/01.HYP.0000130484.20501.df.
Tracy RP. Thrombin, inflammation, and cardiovascular disease: an epidemiologicperspective. Chest. 2003;124(3 Suppl):49S-57S. doi: 10.1378/chest.124.3_suppl.49s.
Eisenhardt SU, Habersberger J, Peter K. Monomeric c-reactive protein generationon activated platelets: the missing link between inflammation and atherothromboticrisk. Trends Cardiovasc Med 2009; 19:232–7. doi: 10.1016/j.tcm.2010.02.002.
Lippi G, Favaloro EJ, Montagnana M, Franchini M. C-reactive protein and venousthromboembolism: causal or causal association? Clin Chem Lab Med 2010;48:1673–701. doi: 10.1515/CCLM.2010.335.
Cholette JM, Rubenstein JS, Alfieris GM, et al. Elevated risk of thrombosis in neonatesundergoing initial palliative cardiac surgery. Ann Thorac Surg 2007; 84:1320–5. doi: 10.1016/j.athoracsur.2007.05.026.
Kaur R, Bhurtel D, Bielefeld MR, et al. Cryopreserved Saphenous vein comparedwith PTFE graft for use as modified Blalock-Taussing or Central Shunt in cyanoticcongenital heart disease. World J Pediatr Congenit Heart Surg 2018;9:509-12. doi:doi: 10.1177/2150135118776616.
Bishnoi, A.K., Talwar, S., Choudhary, S.K. et al. Homograft saphenous vein versuspolytetrafluoroethylene graft for modified Blalock -Taussig shunt. Indian J ThoracCardiovasc Surg 2008;24:227–32. doi: 10.1007/s12055-008-0051-z.
Al Jubair KA, Al Fagih MR, Al Jarallah AS, Al Yousef S, Ali Khan MA, AshmegA, Al Faraidi Y, Sawyer W. Results of 546 Blalock-Taussig shunts performed in 478patients. Cardiol Young 1998;8:486-90. doi: 10.1017/s1047951100007150.
Li JS, Yow E, Berezny KY, Rhodes JF, et al. Clinical outcomes of palliative surgeryincluding a systemic-to-pulmonary artery shunt in infants with cyanotic congenitalheart disease: does aspirin make a difference? Circulation. 2007;116:293-7. doi:10.1161/CIRCULATIONAHA.106.652172.
Sahoo TK, Chauhan S, Sahu M, Bisoi A, Kiran U. Effects of hemodilution on outcomeafter modified Blalock-Taussig shunt operation in children with cyanotic congenitalheart disease. J Cardiothorac Vasc Anesth 2007; 21:179–83. doi: 10.1053/j.jvca.2006.01.029.
Watanabe M, Aoki M, Fujiwara T. Thrombotic occlusion of Blalock- Taussig shuntin a patient with unnoticed protein C deficiency. Gen Thorac Cardiovasc Surg 2008;56:544–6. doi: 10.1007/s11748-008-0295-y.
Deally C, Hancock BJ, Giddins N, Hawkins L, Odim J. Primary antiphospholipidsyndrome: a cause of catastrophic shunt thrombosis in the newborn. J CardiovascSurg 1999; 40:261–4.
Wells WJ, Yu RJ, Batra AS, Monforte H, Sintek C, Starnes VA. Obstruction in modifiedBlalock shunts: a quantitative analysis with clinical correlation. Ann ThoracSurg 2005; 79:2072–6. doi: 10.1016/j.athoracsur.2004.12.050.
Lee C. Surgical management of chronic pulmonary regurgitation after relief of rightventricular outflow tract obstruction. Korean Circ J 2012;42:1-7. doi: 10.4070/kcj.2012.42.1.1.
Arenz C, Laumeier A, Lütter S, et al. Is there any need for a shunt in the treatmentof tetralogy of Fallot with one source of pulmonary blood flow? Eur J CardiothoracSurg 2013;44:648-54. doi: 10.1093/ejcts/ezt124.
Pacileo G, Limongelli G, Verrengia M, et al. Impact of pulmonary regurgitation andage at surgical repair on textural and functional right ventricular myocardial propertiesin patients with tetralogy of Fallot. Ital Heart J 2005; 6:745–50.
Kantorova A, Zbieranek K, Sauer H, Lilje C, Haun C, Hraska V. Primary early correctionof tetralogy of Fallot irrespective of age. Cardiol Young 2008;18:153-7. doi:10.1017/S1047951108001960.
Rao V, Kadletz M, Hornberger LK, Freedom RM, Black MD. Preservation of thepulmonary valve complex in Tetralogy of Fallot: how small is too small? Ann ThoracSurg. 2000;69:176-9; discussion 179-80. doi: 10.1016/s0003-4975(99)01152-2.
Voges I, Fischer G, Scheewe J, et al. Restrictive enlargement of the pulmonaryannulus at surgical repair of tetralogy of Fallot: 10-year experience with a uniformsurgical strategy. Eur J Cardiothorac Surg 2008;34:1041–5. doi: 10.1016/j.ejcts.2008.07.048.
Vida VL, Guariento A, Castaldi B, et al. Evolving strategies for preserving thepulmonary valve during early repair of tetralogy of Fallot: mid-term results. JThorac Cardiovasc Surg 2014;147:687-94; discussion 694-6. doi: 10.1016/j.jtcvs.2013.10.029.
Spiewak M, Biernacka EK, Małek ŁA, et al. Right ventricular outflow tract obstructionas a confounding factor in the assessment of the impact of pulmonary regurgitationon the right ventricular size and function in patients after repair of tetralogy ofFallot. J Magn Reson Imaging 2011;33:1040-6. doi: 10.1002/jmri.22532.
Yuan SM, Jing H. Palliative procedures for congenital heart defects. Arch CardiovascDis. 2009;102(6-7):549-57. doi: 10.1016/j.acvd.2009.04.011.
Milliken JS, Puga FJ, Davidson GK, Schaff HV, Julsrud PR, Mair DD. Staged surgicalrepair of pulmonary atresia, ventricular septal defect and hypoplastic confluentpulmonary arteries. J Thorac Cardiovasc Surg 1986; 91:818-25.
Sullivan ID, Wren C, Stark J, de Leval MR, Macartney FJ, Deanfield JE. Surgicalunifocalization in pulmonary atresia and ventricular septal defect. A realistic goal?Circulation 1988;78(5 Pt 2):III5-13.
Gill CC, Moodie DS, McGoon DC. Staged surgical management of pulmonary atresiawith diminutive pulmonary arteries. J Thorac Cardiovasc Surg 1977;73:36-42.
Kirklin JW, Bargeron LM, Pacifico AD. The enlargement of small pulmonary arteriesby preliminary palliative operations. Circulation 1977; 56:612-7.
Metras D, Chetaille P, Kreitmann B, Fraisse A, Ghez O, Riberi A. Pulmonary atresiawith ventricular septal defect, extremely hypoplastic pulmonary arteries, majoraorto- pulmonary collaterals. Eur J Cardiothorac Surg. 2001;20:590-6; discussion596-7. doi: 10.1016/s1010-7940(01)00855-7.
Pagani FD, Cheatham JP, Beekman RH 3rd, Lloyd TR, Mosca RS, Bove EL. Themanagement of tetralogy of Fallot with pulmonary atresia and diminutive pulmonaryarteries. J Thorac Cardiovasc Surg 1995; 110:1521–33. doi: 10.1016/S0022-5223(95)70076-5.
Rodefeld MD, Reddy VM, Thompson LD, et al. Surgical creation of aortopulmonarywindow in selected patients with pulmonary atresia with poorly developed aortopulmonarycollaterals and hypoplastic pulmonary arteries. J Thorac CardiovascSurg 2002; 123:1147–54. doi: 10.1067/mtc.2002.121685.
Watterson KG, Wilkinson JL, Karl TR, Mee RB. Very small pulmonary arteries:central end-to-side shunt. Ann Thorac Surg 1991; 52:1132–7. doi: 10.1016/0003-4975(91)91294-6.
Duncan BW, Mee RB, Prieto LR, Rosenthal GL, Mesia CI, Qureshi A, TuckerOP, Rhodes JF, Latson LA. Staged repair of tetralogy of Fallot with pulmonaryatresia and major aortopulmonary collateral arteries. J Thorac Cardiovasc Surg2003;126:694-702. doi: 10.1016/s0022-5223(03)00700-1.
Liava'a M, Brizard CP, Konstantinov IE, Robertson T, Cheung MM, Weintraub R,d'Udekem Y. Pulmonary atresia, ventricular septal defect, and major aortopulmonarycollaterals: neonatal pulmonary artery rehabilitation without unifocalization.Ann Thorac Surg 2012;93:185-91. doi: 10.1016/j.athoracsur.2011.08.082.
Mainwaring RD, Reddy M, Perry SB et al. Late Outcomes in Patients UndergoingAortopulmonary Window for Pulmonary Atresia/Stenosis and Major AortopulmonaryCollaterals. Ann Thorac Surg 2012; 94:842–9. doi: 10.1016/j.athoracsur.2012.03.061.
d’Udekem Y,Alphonso N, Nørgaard MA et al. Pulmonary atresia with ventricularseptal defects and major aortopulmonary collateral arteries: Unifocalization bringsno long-term benefits. J Thorac Cardiovasc Surg 2005; 130:1496-502. 10.1016/j.jtcvs.2005.07.034.
Gates RN, Laks H, Johnson K. Side-to-side aorto-Gore-Tex central shunt. Ann ThoracSurg 1998;65:515-6. doi: 10.1016/s0003-4975(97)01126-0.
Kim H, Sung SC, Choi KH, Lee HD, Ban GH, Chang YH. A central shunt to rehabilitatediminutive pulmonary arteries in patients with pulmonary atresia with ventricularseptal defect. J Thorac Cardiovasc Surg 2015;149:515-20. doi: 10.1016/j.jtcvs.2014.10.033.
Gerelli S, van Steenberghe M, Murtuza B, et al. Neonatal right ventricle to pulmonaryconnection as a palliative procedure for pulmonary atresia with ventricularseptal defect or severe tetralogy of Fallot. Eur J Cardiothorac Surg 2014;45:278-88;discussion 288. doi: 10.1093/ejcts/ezt401.
Barbero-Marcial M, Riso A, Atik E, Jatene AA. Technique for correction of truncusarteriosus types I and II without extracardiac conduits. J Thorac Cardiovasc Surg1990; 99:364–9.
Rome JJ, Mayer JE, Castaneda AR, Lock JE. Tetralogy of Fallot with pulmonaryatresia. Rehabilitation of diminutive pulmonary arteries. Circulation. 1993 Oct;88(4Pt 1):1691-8. doi: 10.1161/01.cir.88.4.1691.
Piehler JM, Danielson GK, McGoon DC, Wallace RB, Fulton RE, Mair DD. Managementof pulmonary atresia with ventricular septal defect and hypoplastic pulmonaryarteries by right ventricular outflow construction. J Thorac Cardiovasc Surg1980; 80:552–67.
Van Arsdell G, Yun TJ. An apology for primary repair of tetralogy of Fallot. SeminThorac Cardiovasc Surg Pediatr Card Surg Annu 2005:128-31. doi: 10.1053/j.pcsu.2005.01.016.
Malhotra SP, Hanley FL. Surgical management of pulmonary atresia with ventricularseptal defect and major aortopulmonary collaterals: a protocol-based approach.Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2009:145-51. doi:10.1053/j.pcsu.2009.01.017.
Cho JM, Puga FJ, Danielson GK, et al. Early and long-term results of the surgicaltreatment of tetralogy of Fallot with pulmonary atresia, with or without majoraortopulmonary collateral arteries. J Thorac Cardiovasc Surg 2002;124:70-81. doi:10.1067/mtc.2002.120711.
Farouk A, Zahka K, Siwik E, Erenberg F, Al-Khatib Y, Golden A, Karimi M, UddinM, Hennein HA. Individualized approach to the surgical treatment of tetralogyof Fallot with pulmonary atresia. Cardiol Young 2009;19:76-85. doi: 10.1017/S1047951108003430.
Kim H, Sung SC, Chang YH, Jung W, Lee HD, Park JA, Huh U. Outcome of StagedRepair of Tetralogy of Fallot with Pulmonary Atresia and a Ductus-dependent PulmonaryCirculation: Should Primary Repair Be Considered? Korean J Thorac CardiovascSurg 2011;44:392-8. doi: 10.5090/kjtcs.2011.44.6.392.
O'Connor MJ, Ravishankar C, Ballweg JA, Gillespie MJ, Gaynor JW, Tabbutt S,Dominguez TE. Early systemic-to-pulmonary artery shunt intervention in neonateswith congenital heart disease. J Thorac Cardiovasc Surg. 2011;142:106-12. doi:10.1016/j.jtcvs.2010.10.033.
Virzi L, Pemberton V, Ohye RG, Tabbutt S, Lu M, Atz TC et al. Reporting adverseevents in a surgical trial for complex congenital heart disease: the Pediatric HeartNetwork experience. J Thorac Cardiovasc Surg 2011;142:531–7. doi: 10.1016/j.jtcvs.2010.11.052.
Gibbs JL, Rothman MT, Rees MR, Parsons JM, Blackburn ME, Ruiz CE. Stentingof the arterial duct: a new approach to palliation for pulmonary atresia. Br Heart J1992;67:240-5. doi: 10.1136/hrt.67.3.240.
Rehman R, Marhisham MC, Alwi M. Stenting the complex patent ductus arteriosusin tetralogy of Fallot with pulmonary atresia: challenges and outcomes. Future Cardiol2018;14:55-73. doi: 10.2217/fca-2017-0053.
Santoro G, Gaio G, Giugno L, et al. Ten-years, single-center experience with arterialduct stenting in duct-dependent pulmonary circulation: early results, learning-curvechanges, and mid-term outcome. Catheter Cardiovasc Interv 2015;86:249-57. doi:10.1002/ccd.25949.
Udink Ten Cate FE, Sreeram N, Hamza H, Agha H, Rosenthal E, Qureshi SA.Stenting the arterial duct in neonates and infants with congenital heart disease andduct-dependent pulmonary blood flow: a multicenter experience of an evolvingtherapy over 18 years. Catheter Cardiovasc Interv 2013;82:E233-43. doi: 10.1002/ccd.24878.
Alwi M. Stenting the patent ductus arteriosus in duct-dependent pulmonary circulation:techniques, complications and follow-up. Future Cardiol 2012;8:237-50. doi:10.2217/fca.12.4.
Santoro G, Gaio G, Palladino MT, et al. Arterial duct stenting: Do we still needsurgical shunt in congenital heart malformations with duct-dependent pulmonarycirculation? J Cardiovasc Med (Hagerstown) 2010;11:852-7. doi: 10.2459/JCM.0b013e32833a070d.
Santoro G, Gaio G, Palladino MT, et al. Stenting of the arterial duct in newbornswith duct-dependent pulmonary circulation. Heart 2008;94:925-9. doi: 10.1136/hrt.2007.123000.
Alwi M. Stenting the ductus arteriosus: Case selection, technique and possible complications.Ann Pediatr Cardiol 2008;1:38-45. doi: 10.4103/0974-2069.41054.
Alwi M, Choo KK, Latiff HA, Kandavello G, Samion H, Mulyadi MD. Initial resultsand medium-term follow-up of stent implantation of patent ductus arteriosusin duct-dependent pulmonary circulation. J Am Coll Cardiol 2004;44:438-45. doi:10.1016/j.jacc.2004.03.066.
Glatz AC, Petit CJ, Goldstein BH, et al. A comparison between patent ductus arteriosusstent and modified Blalock-Taussig shunt as palliation for infants with ductal-dependent pulmonary blood flow: insights from the congenital catheterizationresearch collaborative. Circulation 2018;137:581-8. doi: doi: 10.1161/CIRCULATIONAHA.117.029987.
Bentham JR, Zava NK, Harrison WJ, et al. Duct stenting versus modified BlalockTaussig shunt in neonates with duct-dependent pulmonary blood flow: associationswith clinical outcomes in a multicenter national study. Circulation. 2018;137:581-588. doi: 10.1161/CIRCULATIONAHA.117.028972.
Glatz AC, Shah SS, McCarthy AL, Geisser D, Daniels K, Xie D, Hanna BD,Grundmeier RW, Gillespie MJ, Rome JJ. Prevalence of and risk factors for acuteocclusive arterial injury following pediatric cardiac catheterization: a large single-center cohort study. Catheter Cardiovasc Interv 2013;82:454-62. doi: 10.1002/ccd.24737.
Polat TB. Stenting the vertical ductus arteriosus via axillary artery access using"wire-target" technique. Congenital Heart Dis 2017;12:800-7. doi: 10.1111/chd.12512.
Justino H, Petit CJ. Percutaneous Common Carotid Artery Access for PediatricInterventional Cardiac Catheterization. Circ Cardiovasc Interv 2016;9:e003003.doi: 10.1161/CIRCINTERVENTIONS.115.003003.
Choudhry S, Balzer D, Murphy J, Nicolas R, Shahanavaz S. Percutaneous carotidartery access in infants < 3 months of age. Catheter Cardiovasc Interv: Off J SocCardiac Angiogra Interv 2016;87:757-61. doi: 10.1002/ccd.26310.
Schranz D, Michel-Behnke I. Axillary artery access for cardiac interventions innewborns. Ann Pediat Cardiol. 2008;1:126-30. doi: 10.4103/0974-2069.43878.
Alwi M. Patent ductus arteriosus stenting-problems, complications and technicalconsideration. Neonatol Today 2011; 6:3-5. doi: 10.4103/0974-2069.41054.
Michel-Behnke I, Akintuerk H, Thul J, Bauer J, Hagel KJ, Schranz D. Stent implantationin the ductus arteriosus for pulmonary blood supply in congenital heartdisease. Catheter Cardiovasc Interv 2004;61:242-52. doi: 10.1002/ccd.10766.
Buys DG, Brown SC, Greig C. Stenting the arterial duct: practical aspects and reviewof outcomes. SA Heart J 2013; 13:514-9. DOI: https://doi.org/10.24170/10-3-1791.
Gewillig M, Boshoff DE, Dens J, Mertens L, Benson LN. Stenting the neonatalarterial duct in duct-dependent pulmonary circulation: new techniques, better results.J Am Coll Cardiol 2004;43:107-12. doi: 10.1016/j.jacc.2003.08.029.
Matter M, Almarsafawey H, Hafez M, Attia G, Abuelkheir MM. Patent ductusarteriosus stenting in complex congenital heart disease: early and midterm resultsfor a single-center experience at children hospital, Mansoura, Egypt. Pediatr Cardiol.2013;34:1100-6. doi: 10.1007/s00246-012-0608-x.
Schneider M, Zartner P, Sidiropoulos A, Konertz W, Hausdorf G. Stent implantationof the arterial duct in newborns with duct-dependent circulation. Eur Heart J1998;19:1401-9. doi: 10.1053/euhj.1998.0977.
Hussain A, Al-Zharani S, Muhammed AA, Al-Ata J, Galal OM. Midterm outcomeof stent dilatation of patent ductus arteriosus in ductal-dependent pulmonary circulation.Congenit Heart Dis 2008:3:241-9. doi: 10.1111/j.1747-0803.2008.00197.x.
Amoozgar H, Cheriki S, Borzoee M, Ajami G, Soltani M, Ahmadipour M, PeiravianF, Amirghofran A. Short-term result of ductus arteriosus stent implantationcompared with surgically created shunts. Pediatr Cardiol 2012;33:1288-94. doi:10.1007/s00246-012-0304-x.
Onalan MA, Odemis E, Saygi M, et al. Early and midterm results of ductalstent implantation in neonates with ductal-dependent pulmonary circulation:a single-centre experience. Cardiol Young 2020;30:1772-82. doi: 10.1017/S104795112000267X.
Feltes TF, Bacha E, Beekman RH 3rd, et al. Indications for cardiac catheterizationand intervention in pediatric cardiac disease: a scientific statement fromthe American Heart Association. Circulation. 2011;123:2607-52. doi: 10.1161/CIR.0b013e31821b1f10.
Qureshi AM, Goldstein BH, Glatz AC, et al. Classification scheme for ductal morphologyin cyanotic patients with ductal dependent pulmonary blood flow and associationwith outcomes of patent ductus arteriosus stenting. Catheter CardiovascInterv 2019; 93:933-43. doi: 10.1002/ccd.28125.
Santoro G, Gaio G, Capozzi G, Giugno L, Palladino MT, Capogrosso C, D'AielloAF, Caianiello G, Russo MG. Fate of Hypoplastic Pulmonary Arteries AfterArterial Duct Stenting in Congenital Heart Disease with Duct-Dependent PulmonaryCirculation. JACC Cardiovasc Interv 2015;8:1626-32. doi: 10.1016/j.jcin.2015.05.027.
Sivakumar K, Bhagyavathy A, Coelho R, Satish R, Krishnan P. Longevity ofneonatal ductal stenting for congenital heart diseases with duct-dependent pulmonarycirculation. Congenit Heart Dis 2012;7:526-33. doi: 10.1111/j.1747-0803.2012.00657.x.
Vida VL, Speggiorin S, Maschietto N, et al. Cardiac operations after patent ductusarteriosus stenting in duct-dependent pulmonary circulation. Ann Thorac Surg.2010;90:605-9. doi: 10.1016/j.athoracsur.2010.04.007.
Santoro G, Capozzi G, Caianiello G, et al. Pulmonary artery growth after palliationof congenital heart disease with duct-dependent pulmonary circulation: arterialduct stenting versus surgical shunt. J Am Coll Cardiol 2009;54:2180-6. doi:10.1016/j.jacc.2009.07.043.
McMullan DM, Permut LC, Jones TK, Johnston TA, Rubio AE. ModifiedBlalock-Taussig shunt versus ductal stenting for palliation of cardiac lesions withinadequate pulmonary blood flow. J Thorac Cardiovasc Surg 2014;147:397-401.doi: 10.1016/j.jtcvs.2013.07.052
Mallula K, Vaughn G, El-Said H, Lamberti JJ, Moore JW. Comparison of ductalstenting versus surgical shunts for palliation of patients with pulmonary atresiaand intact ventricular septum. Catheter Cardiovasc Interv 2015;85:1196-202. doi:doi: 10.1002/ccd.25870.
Gibbs JL, Uzun O, Blackburn ME, Parsons JM, Dickinson DF. Right ventricularoutflow stent implantation: an alternative to palliative surgical relief of infundibularpulmonary stenosis. Heart 1997; 77:176 - 9. doi: 10.1136/hrt.77.2.176.
Stumper O, Ramchandani B, Noonan P, et al. Stenting of the right ventricularoutflow tract. Heart 2013;99:1603-8. doi: 10.1136/heartjnl-2013-304155.
Shenoy AR, Padmakumar P, Subashchandra V. Right ventricular outflow tractstenting in Tetralogy of Fallot with restrictive ventricular septal defect. J InvasiveCardiol 2006;18(1):E59-60.
Dryzek P, Mazurek-Kula A, Moszura T, Sysa A. Right ventricle outflow tractstenting as a method of palliative treatment of severe tetralogy of Fallot. Cardiol J2008;15:376-9.
Zeidenweber CM, Kim DW, Vincent RN. Right ventricular outflow tract and pulmonaryartery stents in children under 18 months of age. Catheter CardiovascInterv 2007;69:23-7. doi: 10.1002/ccd.20918.
Barron DJ, Ramchandani B, Murala J, et al. Surgery following primary right ventricularoutflow tract stenting for Fallot's tetralogy and variants: rehabilitation ofsmall pulmonary arteries. Eur J Cardiothorac Surg 2013;44:656-62. doi: 10.1093/ejcts/ezt188.
Bang S, Ko HK, Yu JJ, et al. Right ventricular outflow tract stenting in a low birthweight infant born with tetralogy of Fallot and prostaglandin e1 dependency. KoreanCirc J 2011;41:744-6. doi: 10.4070/kcj.2011.41.12.744.
Dohlen G, Chaturvedi RR, Benson LN, et al. Stenting of the right ventricular outflowtract in the symptomatic infant with tetralogy of Fallot. Heart 2009;95:142-7.doi: 10.1136/hrt.2007.135723.
Linnane N, Walsh KP, McGuinness J, Kenny D. Evolution of Approach to RightVentricular Outflow Tract Stenting in Infants ≤ 2Kgs. Journal of Structural HeartDisease 2018;4(2):50-5. 0.12945/j.jshd.2018.045.17.
Castleberry CD, Gudausky TM, Berger S, Tweddell JS, Pelech AN. Stenting of theright ventricular outflow tract in the high-risk infant with cyanotic teratology ofFallot. Pediatr Cardiol 2014;35:423-30. doi: 10.1007/s00246-013-0796-z.
Quandt D, Ramchandani B, Stickley J, et al. Stenting of the Right VentricularOutflow Tract Promotes Better Pulmonary Arterial Growth Compared with ModifiedBlalock-Taussig Shunt Palliation in Tetralogy of Fallot-Type Lesions. JACCCardiovasc Interv 2017;10:1774-84. doi: 10.1016/j.jcin.2017.06.023.
Backes CH, Cua C, Kreutzer J, et al. Low weight as an independent risk factorfor adverse events during cardiac catheterization of infants. Catheter CardiovascInterv 2013;82:786-94. doi: 10.1002/ccd.24726.
Hosking MC, Benson LN, Nakanishi T, Burrows PE, Williams WG, Freedom RM.Intravascular stent prosthesis for right ventricular outflow obstruction. J Am CollCardiol 1992;20:373-80. doi: 10.1016/0735-1097(92)90105-v.
Gibbs JL, Uzun O, Blackburn ME, Parsons JM, Dickinson DF. Right ventricularoutflow stent implantation: an alternative to palliative surgical relief of infundibularpulmonary stenosis. Heart 1997;77(2):176-9. doi: 10.1136/hrt.77.2.176.
Bertram H, Emmel M, Ewert P, et al; Investigators Of The Working Group InterventionalCardiology Of The German Society Of Pediatric Cardiology. Stentingof Native Right Ventricular Outflow Tract Obstructions in Symptomatic Infants. JInterv Cardiol 2015;28:279-87. doi: 10.1111/joic.12198.